A review of factors contributing to health related quality of life achieved with cardiac resynchronization therapy for heart failure

Minerva Cardioangiologica

Volumn 55, Issue 6, 2007, Pages 783-802

  Van Hemel, N M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cardiac pacing, artificial; Cardiac resynchronisation therapy; Defibrillators, implantable; Heart failure, congestive; Quality of life

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; LIFE EXPECTANCY; MORBIDITY; MORTALITY; QUALITY OF LIFE; REVIEW;

COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 38649107666     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Kass DA, Chen CH, Curry C, Talbot M, Berger R, Fetics B et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567-73.
2. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999;99:2993-3001.
3. Blanc JJ, Etienne Y, Gilard M, Mansourati J, Munier S, Boschat J et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 1997;96:3273-7.
4. Leclercq C, Cazeau S, Le Breton H, Ritter P, Mabo P, Gras D et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825-31.
5. Daubert JC, Ritter P, Le Breton H, Gras D, Leclercq C, Lazarus A et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 1998;21:239-45.
6. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
7. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
8. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33.
9. Gras D, Leclercq C, Tang AS, Bucknall C, Luttikhuis HO, Kirstein-Pedersen A. Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur J Heart Fail 2002;4:311-20.
10. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-8.
11. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
12. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-94.
13. Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 1999;33:1735-42.
14. Prinzen FW, Peschar M. Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing Clin Electrophysiol 2002;25:484-98.
15. Xiao HB, Roy C, Gibson DG. Nature of ventricular activation in patients with dilated cardiomyopathy: evidence for bilateral bundle branch block. Br Heart J 1994;72:167-74.
16. Wiegerinck RF, Verkerk AO, Belterman CN, van Veen TA, Baartscheer A, Opthof T et al. Larger cell size in rabbits with heart failure increases myocardial conduction velocity and QRS duration. Circulation 2006;113: 806-13.
17. Eriksson P, Wilhelmsen L, Rosengren A. Bundle-branch block in middle-aged men: risk of complications and death over 28 years. The Primary Prevention Study in Goteborg, Sweden. Eur Heart J 2005;26:2300-6.
18. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002;143:398-405.
19. Mehdirad AA, Nelson SD, Love CJ, Schaal SF, Tchou PJ. QRS duration widening: reduced synchronization of endocardial activation or transseptal conduction time? Pacing Clin Electrophysiol 1998;21:1589-94.
20. Cazeau S, Gras D, Lazarus A, Ritter P, Mugica J. Multisite stimulation for correction of cardiac asynchrony. Heart 2000;84:579-81.
21. Tse HF, Lee KL, Wan SH, Yu Y, Hoersch W, Pastore J et al. Area of left ventricular regional conduction delay and preserved myocardium predict responses to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2005;16:690-5.
22. Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC et al. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation 2001;104:3069-75.
23. Auricchio A, Fantoni C, Regoli F, Carbucicchio C, Goette A, Geller C et al. Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation 2004;109:1133-9.
24. Toquero J, Geelen P, Goethals M, Brugada P. What is first, left bundle branch block or left ventricular dysfunction? J Cardiovasc Electrophysiol 2001;12:1425-8.
25. Jansen AH, van Dantzig J, Bracke F, Peels KH, Koolen JJ, Meijer A et al. Improvement in diastolic function and left ventricular filling pressure induced by cardiac resynchronization therapy. Am Heart J 2007;153:843-9.
26. Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol 2003;42:2117-24.
27. Bleeker GB, Holman ER, Steendijk P, Boersma E, Van Der Wall EE, Schalij MJ et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006;48:2243-50.
28. Rajagopalan N, Dohi K, Simon MA, Suffoletto M, Edelman K, Murali S et al. Right ventricular dyssynchrony in heart failure: a tissue Doppler imaging study. J Card Fail 2006;12:263-7.
29. Molhoek SG, van Erven L, Bootsma M, Steendijk P, Van Der Wall EE, Schalij MJ. QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure. Pacing Clin Electrophysiol 2004;27:308-13.
30. Lecoq G, Leclercq C, Leray E, Crocq C, Alonso C, de Place C et al. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J 2005;26:1094-100.
31. Coats AJ. Heart failure: What causes the symptoms of heart failure? Heart 2001;86:574-8.
32. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 1994;90:2772-9.
33. Skaluba SJ, Litwin SE. Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation 2004;109:972-7.
34. Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002;87:235-41.
35. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 1993;71:1106-7.
36. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
37. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667-75.
38. McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004;141:381-90.
39. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
40. Cohen J. Statistical power analysis of the behavioral sciences. Hilsdale: Lawrence Erlbaum Associates; 1988.
41. Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H et al. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care 2007;45:377-85.
42. Bennett SJ, Huster GA, Baker SL, Milgrom LB, Kirchgassner A, Birt J et al. Characterization of the precipitants of hospitalization for heart failure decompensation. Am J Crit Care 1998;7:168-74.
43. de Groote P, Millaire A, Foucher-Hossein C, Nugue O, Marchandise X, Ducloux G et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998;32:948-54.
44. Reynolds MR, Joventino LP, Josephson ME. Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure. Pacing Clin Electrophysiol 2004;27:1513-8.
45. Fruhwald FM, Fahrleitner-Pammer A, Berger R, Leyva F, Freemantle N, Erdmann E et al. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J 2007;28:1592-7.
46. Bleeker GB, Schalij MJ, Nihoyannopoulos P, Steendijk P, Molhoek SG, van Erven L et al. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol 2005;46:2264-9.
47. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-7.
48. Lee KL, Burnes JE, Mullen TJ, Hettrick DA, Tse HF, Lau CP. Avoidance of right ventricular pacing in cardiac resynchronization therapy improves right ventricular hemodynamics in heart failure patients. J Cardiovasc Electrophysiol 2007;18:497-504.
49. de Cock CC, Giudici MC, Twisk JW. Comparison of the haemodynamic effects of right ventricular outflow-tract pacing with right ventricular apex pacing: a quantitative review. Europace 2003;5:275-8.
50. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
51. Higgins SL, Yong P, Sheck D, McDaniel M, Bollinger F, Vadecha M et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators. J Am Coll Cardiol 2000;36:824-7.
52. Medina-Ravell VA, Lankipalli RS, Yan GX, Antzelevitch C, Medina-Malpica NA, Medina-Malpica OA et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 2003;107:740-6.
53. McSwain RL, Schwartz RA, Delurgio DB, Mera FV, Langberg JJ, Leon AR. The impact of cardiac resynchronization therapy on ventricular tachycardia/ fibrillation: an analysis from the combined Contak-CD and InSync-ICD studies. J Cardiovasc Electrophysiol 2005;16:1168-71.
54. McAlister FA, Ezekowitz J, Dryden DM, Hooton N, Vandermeer B, Friesen C et al. Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction. Evid Rep Technol Assess 2007;1-199.
55. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Europace 20079:959-98.
56. Bax JJ, Molhoek SG, van Erven L, Voogd PJ, Somer S, Boersma E et al. Usefulness of myocardial tissue Doppler echocardiography to evaluate left ventricular dyssynchrony before and after biventricular pacing in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2003;91:94-7.
57. Kim WY, Sogaard P, Mortensen PT, Jensen HK, Pedersen AK, Kristensen BO et al. Three dimensional echocardiography documents haemodynamic improvement by biventricular pacing in patients with severe heart failure. Heart 2001;85:514-20.
58. Hawkins NM, Petrie MC, MacDonald MR, Hogg KJ, McMurray JJ. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? Eur Heart J 2006;27:1270-81.
59. Jansen AH, Bracke FA, van Dantzig JM, Meijer A, Van Der Voort PH, Aarnoudse W et al. Correlation of echo-Doppler optimization of atrioventricular delay in cardiac resynchronization therapy with invasive hemodynamics in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2006;97:552-7.
60. Yu CM, Fung JW, Chan CK, Chan YS, Zhang Q, Lin H et al. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure. J Cardiovasc Electrophysiol 2004;15:1058-65.
61. Garrigue S, Bordachar P, Reuter S, Jais P, Kobeissi A, Gaggini G et al. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study. Heart 2002;87:529-34.
62. Molhoek SG, Bax JJ, Bleeker GB, Boersma E, van Erven L, Steendijk P et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004;94:1506-9.
63. Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 2007;99:1252-7.
64. Horwich T, Foster E, De Marco T, Tseng Z, Saxon L. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices. J Cardiovasc Electrophysiol 2004;15:1284-9.
65. Delnoy PP, Ottervanger JP, Luttikhuis HO, Nicastia DM, Elvan A, Misier AR et al. Sustained benefit of cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2007;18:298-302.
66. Breithardt G. Cardiac resynchronization therapy into the next decade: from the past to morbidity/mortality trials. Eur.Heart J 2002:D102-D110.
67. Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000;21:1238-45.
68. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991;84:40-8.
69. Vogt J, Schwarz T, Gras D, Sperzel J, Ritter P, de Voogt W et al. The use of telescoping guide catheters for coronary sinus cannulation and sub-selecting tributaries in left ventricular lead placement. J Interv Card Electrophysiol 2007;19:61-8.
70. de Voogt WG, van Mechelen R, van den Bos AA, Scheffer M, van Hemel NM, Levine PA. Electrical characteristics of low atrial septum pacing compared with right atrial appendage pacing. Europace 2005;7:60-6.
71. Buckingham TA. Right ventricular outflow tract pacing. Pacing Clin Electrophysiol 1997;20:1237-42.
72. Stambler BS, Ellenbogen K, Zhang X, Porter TR, Xie F, Malik R et al. Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:1180-6.
73. Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007;357:1000-8.
74. Butter C, Auricchio A, Stellbrink C, Fleck E, Ding J, Yu Y et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001;104:3026-9.
75. Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol 2002;39:489-99.
76. van Campen CM, Visser FC, de Cock CC, Vos HS, Kamp O, Visser CA. Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation. Heart 2006;92:1795-800.
77. Ellenbogen KA, Hellkamp AS, Wilkoff BL, Camunas JL, Love JC, Hadjis TA et al. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol 2003;92:740-1.
78. van Eck JW, van Hemel NM, Zuithof P, van Asseldonk JP, Voskuil TL, Grobbee DE et al. Incidence and predictors of in-hospital events after first implantation of pacemakers. Europace 2007;9:884-9.
79. van Hemel NM, Holwerda KJ, Siegers PC, Spierenburg HA, Timmermans AA, Meeder JG et al. The contribution of rate adaptive pacing with single or dual sensors to health-related quality of life. Europace 2007;9:233-8.
80. Van Beeumen K, Duytschaever M, Tavernier R, Van de Veire N, De Sutter J. Intra- and interatrial asynchrony in patients with heart failure. Am J Cardiol 2007;99:79-83.
81. Doshi RN. Optimizing resynchronization therapy: can we increase the number of true responders? J Cardiovasc Electrophysiol 2005;16 (Suppl 1):S48-S51.
82. Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002;105:1304-10.
83. Van Gelder BM, Bracke FA, Van Der Voort PH, Meijer A. Optimal sensed atrio-ventricular interval determined by paced QRS morphology. Pacing Clin Electrophysiol 2007;30:476-81.
84. Levin V, Nemeth M, Colombowala I, Massumi A, Rasekh A, Cheng J et al. Interatrial conduction measured during biventricular pacemaker implantation accurately predicts optimal paced atrioventricular intervals. J Cardiovasc Electrophysiol 2007;18:290-5.
85. Ritter P, Padeletti L, Gillio-Meina L, Gaggini G. Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Europace 1999;1:126-30.
86. Gold MR, Niazi I, Giudici M, Leman RB, Sturdivant JL, Kim MH et al. A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2007;18:490-6.
87. Rouleau F, Merheb M, Geffroy S, Berthelot J, Chaleil D, Dupuis JM et al. Echocardiographic assessment of the interventricular delay of activation and correlation to the QRS width in dilated cardiomyopathy. Pacing Clin Electrophysiol 2001;24:1500-6.
88. Van Gelder BM, Bracke FA, Meijer A, Lakerveld LJ, Pijls NH. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol 2004;93:1500-3.
89. Steendijk P, Tulner SA, Schreuder JJ, Bax JJ, van Erven L, van Der Wall EE et al. Quantification of left ventricular mechanical dyssynchrony by conductance catheter in heart failure patients. Am J Physiol Heart Circ Physiol 2004;286:H723-H730.
90. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834-40.
91. Sogaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BO et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:723-30.
92. Jansen AH, Bracke F, van Dantzig JM, Meijer A, Korsten EH, Peels KH et al. Optimization of pulsed wave tissue Doppler to predict left ventricular reverse remodeling after cardiac resynchronization therapy. J Am Soc Echocardiogr 2006;19:185-91.
93. Yu CM, Fung JW, Zhang Q, Chan CK, Chan YS, Lin H et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation 2004;110:66-73.
94. Vanderheyden M, De Backer T, Rivero-Ayerza M, Geelen P, Bartunek J, Verstreken S et al. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy. Heart Rhythm 2005;2: 1066-72.
95. Jenkins C, Bricknell K, Hanekom L, Marwick TH. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol 2004;44:878-86.
96. Herbst JH, Goodman M, Feldstein S, Reilly JM. Health-related quality-of-life assessment of patients with life-threatening ventricular arrhythmias. Pacing Clin Electrophysiol 1999;22:915-26.
97. Rees K, Taylor RS, Singh S, Coats AJ, Ebrahim S. Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev 2004;CD003331.
98. Braunschweig F, Linde C, Gadler F, Ryden L. Reduction of hospital days by biventricular pacing. Eur J Heart Fail 2000;2:399-406.
99. Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC et al. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J 2005;26:2681-8.
100. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007;28:42-51.
101. Nichol G, Kaul P, Huszti E, Bridges JF. Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure. Ann Intern Med 2004;141:343-51.
102. Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C et al. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. Health Technol Assess 2006;10:1-164.
103. Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76.
104. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001;7:176-82.
105. Stelbrink C. How to discriminate resonders from non-responders to cardiac resynchronisation therapy. Eur Heart J 1-8-2004: D101-D105.
106. Cappola TP, Harsch MR, Jessup M, Abraham WT, Young JB, Petersen-Stejskal S et al. Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender. J Card Fail 2006;12:182-8.
107. Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, Van Der Wall EE et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005;112:1580-6.